Acute Ischemic Stroke Diagnosis and Treatment Market Expected to Reach $9.2 Billion by 2032—Allied Market Research

According to a new report published by Allied Market Research, titled, “Acute Ischemic Stroke Diagnosis and Treatment Market," The acute ischemic stroke diagnosis and treatment market size was valued at $5.1 billion in 2022, and is estimated to reach $9.2 billion by 2032, growing at a CAGR of 6.1% from 2023 to 2032.

An acute ischemic stroke occurs when there is a sudden blockage of blood flow to the brain, leading to a lack of oxygen and nutrients. This can result in damage to brain cells and subsequent neurological impairment. Prompt diagnosis and treatment are crucial to minimize long-term consequences. Ischemic strokes are the most common type of strokes and occur when a blood vessel supplying the brain is blocked, usually by a blood clot. This blockage prevents blood flow to a specific region of the brain, resulting in damage to brain tissue. 

The rise in prevalence of ischemic stroke cases is a significant driver for the acute ischemic stroke diagnosis market. As the aging population increases and lifestyle factors contribute to a higher risk of stroke, the demand for accurate and timely diagnosis also grows. In addition, continuous advancements in medical technologies, such as thrombectomy devices, clot retrieval systems, and neuroimaging techniques, contribute to the improvement of acute ischemic stroke treatment outcomes and proples the growth of acute ischemic stroke treatment market.

Further, continuous advancements in imaging technologies, such as computed tomography (CT), magnetic resonance imaging (MRI), and angiography, play a crucial role in the early and accurate diagnosis of acute ischemic stroke and drive the acute ischemic stroke diagnosis market growth. Advanced imaging techniques help healthcare professionals assess the extent of brain damage and determine the most appropriate treatment strategies. 

However, high cost of ischemic stroke treatment restrains market growth. The cost of diagnosis and hospitalization raises the overall cost of stroke management. These high costs can limit access to quality care and negatively impact the market growth. Further, shortage of skilled neurologists and stroke specialists further limit the market growth. On the other hand, rise in technological advancements and high growth rate exhibited by developing economies are expected to present lucrative opportunities for key players in the acute ischemic stroke diagnosis and treatment market during the forecast period. 

The acute ischemic stroke diagnosis and treatment market size is segmented on the basis of type, end user, and region. On the basis of type, the acute ischemic stroke diagnosis and treatment industry is categorized into diagnostics and treatment. The diagnostics segment is further categorized into computed tomography, magnetic resonance imaging, carotid ultrasound, cerebral angiography, electrocardiography, echocardiography, and others. The treatment segment is bifurcated into thrombolytic therapy and mechanical thrombectomy. The thrombolytic therapy segment is further classified into tissue plasminogen activator, antiplatelet, and others. The mechanical thrombectomy segment categorized into stent retriever, aspiration catheter, and combination (Stent retriever and Aspiration catheter). 

The treatment segment accounted for the largest acute ischemic stroke diagnosis and treatment market analysis in 2022 and is expected to register the highest CAGR during the acute ischemic stroke diagnosis and treatment market forecast period. This is attributed to rise in adoption of advanced treatment modalities, success of mechanical thrombectomy, advancements in treatment and efficacy of advanced treatment modalities. In addition, rise in demand for the treatment options such as tissue plaminogen activator and mechanical thrombectomy further drive the acute ischemic stroke treatment market size.

On the basis of end user, the acute ischemic stroke diagnosis and treatment industry is categorized into hospitals and clinics, ambulatory surgery centers, diagnostic laboratories and imaging centers, and others. The hospitals and clinics segment accounted for the largest acute ischemic stroke diagnosis and treatment market share in 2022, owing to their central role as comprehensive care providers, equipped with advanced diagnostic capabilities, specialized stroke units, and the capacity to deliver timely and coordinated interventions. 

However, the diagnostic laboratories and imaging centers segment is expected to register the highest CAGR during the forecast period owing to advancements in imaging technologies, surge in importance of early and accurate diagnosis, and availability of advanced equipment in acute ischemic stroke care. 

Region wise, North America dominated the acute ischemic stroke diagnosis and treatment market, owing to well-established healthcare system, rise in number of people suffering from acute ischemic stroke, technological advancement in diagnostics, strong presence of market key players, and rise in number of product approvals. In addition, significant investments in research and development in the medical sector and modernization of healthcare facilities drive the acute ischemic stroke treatment market size.

However, Asia-Pacific is anticipated to witness notable growth owing to increase in government initiatives to spread awareness about stroke, rise in incidence of stroke, improvements in healthcare infrastructure, surge in awareness about early diagnosis and treatment, and rise in technological advancements. In addition, investments in healthcare infrastructure and the expansion of medical facilities in many Asia-Pacific countries enhance the accessibility of acute ischemic stroke treatments which proples the acute ischemic stroke diagnosis and treatment market trends.

Key Findings of the Study 

• On the basis of type, the treatment segment was the largest contributor to the market in 2022. 
• On the basis of end user, the hospitals and clinics segment was the largest contributor to the market in 2022. 
• Region wise, North America generated the largest revenue in 2022. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.